Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Foley

Showing results (801-810 of 911) with videos related to

Pageof 92
Sort By:
Circulation. Cardiovascular Imaging|July 5, 2017
Acute Infarct Extracellular Volume Mapping to Quantify Myocardial Area at Risk and Chronic Infarct Size on Cardiovascular Magnetic Resonance ImagingPankaj Garg, David A Broadbent, Peter P Swoboda, et al.
Scientific Reports|September 28, 2018
Impact of Age and Diastolic Function on Novel, 4D flow CMR Biomarkers of Left Ventricular Blood Flow Kinetic EnergySaul Crandon, Jos J M Westenberg, Peter P Swoboda, et al.
Nature|February 17, 2012
Light echoes reveal an unexpectedly cool η Carinae during its nineteenth-century Great EruptionA Rest, J L Prieto, N R Walborn, et al.
Protein Expression and Purification|March 20, 2009
Optimized procedures for producing biologically active chemokinesQuinn Lu, Matthew C Burns, Patrick J McDevitt, et al.
Journal of Medicinal Chemistry|March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptorKatherine L Widdowson, John D Elliott, Daniel F Veber, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonistsJian Jin, Dashyant Dhanak, Steven D Knight, et al.
British Journal of Pharmacology|March 21, 2006
The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systemsDavid J Behm, Gerald Stankus, Christopher P A Doe, et al.
Physical Review Letters|May 18, 2013
Leptonic-decay-constant ratio f(K+)/f(π+) from lattice QCD with physical light quarksA Bazavov, C Bernard, C DeTar, et al.
Nature|July 27, 1999
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1J Chambers, R S Ames, D Bergsma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 12, 2024
A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trialMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Pageof 92

Showing results (801-810 of 911) with videos related to

Sort By:
Pageof 92
Circulation. Cardiovascular Imaging|July 5, 2017
Acute Infarct Extracellular Volume Mapping to Quantify Myocardial Area at Risk and Chronic Infarct Size on Cardiovascular Magnetic Resonance ImagingPankaj Garg, David A Broadbent, Peter P Swoboda, et al.
Scientific Reports|September 28, 2018
Impact of Age and Diastolic Function on Novel, 4D flow CMR Biomarkers of Left Ventricular Blood Flow Kinetic EnergySaul Crandon, Jos J M Westenberg, Peter P Swoboda, et al.
Nature|February 17, 2012
Light echoes reveal an unexpectedly cool η Carinae during its nineteenth-century Great EruptionA Rest, J L Prieto, N R Walborn, et al.
Protein Expression and Purification|March 20, 2009
Optimized procedures for producing biologically active chemokinesQuinn Lu, Matthew C Burns, Patrick J McDevitt, et al.
Journal of Medicinal Chemistry|March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptorKatherine L Widdowson, John D Elliott, Daniel F Veber, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonistsJian Jin, Dashyant Dhanak, Steven D Knight, et al.
British Journal of Pharmacology|March 21, 2006
The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systemsDavid J Behm, Gerald Stankus, Christopher P A Doe, et al.
Physical Review Letters|May 18, 2013
Leptonic-decay-constant ratio f(K+)/f(π+) from lattice QCD with physical light quarksA Bazavov, C Bernard, C DeTar, et al.
Nature|July 27, 1999
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1J Chambers, R S Ames, D Bergsma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 12, 2024
A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trialMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Pageof 92